ConductScience.org, home

Trial · NCT07456085

Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves

NCT07456085, Phase 3, Enrolling by invitation, Rawalpindi Institute of Cardiology

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves. Trials, record NCT07456085. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07456085

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves
NCT number
NCT07456085
Status
Enrolling by invitation
Phases
Phase 3
Enrollment
60 participants, estimated
Lead sponsor
Rawalpindi Institute of Cardiology
Conditions
Valvular Heart Disease Patients
Interventions
Rivoroxaban, Warfarin
First posted
2026-03-06
Last updated
2026-03-16

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIncidence of Thromboembolic Events12 months from treatment initiation
Description: Incidence of participants experiencing at least one thromboembolic event (stroke, TIA, prosthetic valve thrombosis, DVT, or PE) during follow-up. Unit of Measure: Number of participants with ≥1 event; proportion (%)
SecondaryIncidence of Major Bleeding12 monthsDescription: Number of participants experiencing at least one major bleeding event (defined according to ISTH criteria). Unit of Measure: Number of participants; proportion (%)
SecondaryIncidence of Clinically Relevant Non-Major Bleeding (if applicable)12 monthsDescription: Number of participants experiencing at least one clinically relevant non-major bleeding event. Unit of Measure: Number of participants; proportion (%)
SecondaryAll-Cause Mortality12 monthsDescription: Number of participants who die from any cause during follow-up. Unit of Measure: Number of deaths; proportion (%)
SecondaryAnticoagulation-Related Hospital Visits12 monthsDescription: Number of hospital or clinic visits related to anticoagulation management during follow-up. Unit of Measure: Number of visits (count)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
27030066BACKGROUNDPubMed
31837559BACKGROUNDPubMed
33150497BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07456085

GET https://conductscience.org/api/trials/v1/NCT07456085/registered